Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-13-051796
Filing Date
2013-06-27
Accepted
2013-06-27 11:53:30
Documents
2
Effectiveness Date
2013-06-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a13-15761_1defa14a.htm DEFA14A 39679
2 GRAPHIC g157611bci001.jpg GRAPHIC 16006
  Complete submission text file 0001104659-13-051796.txt   62853
Mailing Address 707 STATE ROAD NEW JERSEY NJ 08540
Business Address 707 STATE ROAD NEW JERSEY NJ 08540 908-741-4323
Omthera Pharmaceuticals, Inc. (Filer) CIK: 0001477598 (see all company filings)

EIN.: 263797738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35869 | Film No.: 13936495
SIC: 2834 Pharmaceutical Preparations